| 1 | Study | 4% | |
| 2 | Screens | 1.33% | |
| 3 | Case | 1.33% | |
| 4 | Binge | 0.67% | |
| 5 | Animal | 0.67% | |
| 6 | LivaNova’s | 0.67% | |
| 7 | Effectively | 0.67% | |
| 8 | Gut | 0.67% | |
| 9 | Tolerance | 0.67% | |
| 10 | Strategies | 0.67% | |
| 11 | Endocrine | 0.67% | |
| 12 | Office | 0.67% | |
| 13 | Effectiveness | 0.67% | |
| 14 | Non-occlusive | 0.67% | |
| 15 | Resistance | 0.67% | |
| 16 | Evidence | 0.67% | |
| 17 | Antidepressant | 0.67% | |
| 18 | NR2F2 | 0.67% | |
| 19 | Drug | 0.67% | |
| 20 | Sabah | 0.67% | |
| 21 | Ischemia | 0.67% | |
| 22 | Mesenteric | 0.67% | |
| 23 | Oral | 0.67% | |
| 24 | Could | 0.67% | |
| 25 | Detected | 0.67% | |
| 26 | Title | 0.67% | |
| 27 | Dengue’ | 0.67% | |
| 28 | Modeling | 0.67% | |
| 29 | Comorbidities | 0.67% | |
| 30 | Nanoparticle | 0.67% | |
| 31 | Assessment | 0.67% | |
| 32 | Regulator | 0.67% | |
| 33 | Prevalence | 0.67% | |
| 34 | Adherence | 0.67% | |
| 35 | Awareness | 0.67% | |
| 36 | UConn | 0.67% | |
| 37 | Therapy | 0.67% | |
| 38 | Validates | 0.67% | |
| 39 | Both | 0.67% | |
| 40 | Severe | 0.67% | |
| 41 | Uncover | 0.67% | |
| 42 | Eating | 0.67% | |
| 43 | Al-Qunfudhah | 0.67% | |
| 44 | Patients | 0.67% | |
| 45 | Colorectal | 0.67% | |
| 46 | Have | 0.67% | |
| 47 | Diabetes | 0.67% | |
| 48 | mRNA | 0.67% | |
| 49 | Takeda | 0.67% | |
| 50 | Arabia | 0.67% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||